BENGALURU : Coronavirus cases have crossed the two-lakh mark in India, and to keep up, government regulatory authorities have fast-tracked processes for development of vaccines and medication.The process of taking research to the market has been shortened from 18 months to three weeks whether it is approval for clinical trials for new drugs or manufacture of oxygen and hand sanitisers.A regulatory authority for vaccines and drugs, Central Drugs Standard Control Organisation (CDSCO) under the directorate General of Health Services (MoHFW), has fast-tracked all processes and cut red tapism significantly. “We are issuing manufacturing licences in three days, clinical trial approvals for vaccines and new drugs are given in two to five days, and.